Loading clinical trials...
Loading clinical trials...
Mucopolysaccharidosis (MPS) type II (MPS II; Hunter syndrome) is a rare, X-linked disease caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase (I2S) and occurs almost exclusively in bo...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shire
NCT05494593 · Mucopolysaccharidosis (MPS), Hunter Syndrome
NCT02350816 · Sanfilippo Syndrome, Mucopolysaccharidosis (MPS)
Children's Hospital Los Angeles
Los Angeles, California
Nemours Children's Clinic
Jacksonville, Florida
Children's Hospital and Clinic
Minneapolis, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions